FOSTER CITY, Calif., February 19, 2025--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted equity awards covering ...

Claude Makelele has revealed he told Aurelien Tchouameni he needed to get minutes for Real Madrid no matter what, and the £80m man has shown his versatility against Manchester City in this season ...

Analysts' ratings for Geron (NASDAQ:GERN) over the last quarter vary from bullish to bearish, as provided by 4 analysts. The following table provides a quick overview of their recent ratings ...

In the assessment of 12-month price targets, analysts unveil insights for Geron, presenting an average target of $6.38, a high estimate of $9.00, and a low estimate of $3.50. Experiencing a 3.63% ...